David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$751M |
| 2 |
Advanced Micro Devices
AMD
|
+$751M |
| 3 |
Micron Technology
MU
|
+$426M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$363M |
| 5 |
ExxonMobil
XOM
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$546M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$485M |
| 3 |
VMW
VMware, Inc
VMW
|
+$393M |
| 4 |
Microsoft
MSFT
|
+$336M |
| 5 |
UnitedHealth
UNH
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.03% |
| 2 | Consumer Discretionary | 9.51% |
| 3 | Healthcare | 5.77% |
| 4 | Financials | 5.47% |
| 5 | Communication Services | 4.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Macy's
M
$6B
| $2.61M | ﹤0.01% |
129,636
-102,617
| -44% | -$1.48M |
|
2327
PUT
M/I Homes
MHO
$3.85B
| $2.6M | ﹤0.01% |
18,900
| – | – |
|
2328
PUT
Bath & Body Works
BBWI
$3.81B
| $2.59M | ﹤0.01% |
60,000
| – | – |
|
|
GTM
2329
PUT
ZoomInfo Technologies
GTM
$1.11B
| $2.59M | ﹤0.01% |
+140,000
| New | +$2.2M |
|
|
TIXT
2330
DELISTED
TELUS International
TIXT
| $2.58M | ﹤0.01% |
300,394
+37,687
| +14% | +$274K |
|
2331
LGI Homes
LGIH
$1.35B
| $2.57M | ﹤0.01% |
19,319
-19,092
| -50% | -$2.12M |
|
2332
Graham Holdings Company
GHC
$4.93B
| $2.57M | ﹤0.01% |
3,692
-2,458
| -40% | -$1.53M |
|
2333
ThredUp
TDUP
$361M
| $2.57M | ﹤0.01% |
1,142,445
+43,751
| +4% | +$114K |
|
2334
i3 Verticals
IIIV
$306M
| $2.57M | ﹤0.01% |
121,239
+41,339
| +52% | +$829K |
|
2335
Insperity
NSP
$1.98B
| $2.56M | ﹤0.01% |
+21,872
| New | +$2.37M |
|
2336
PUT
Lumentum
LITE
$84.2B
| $2.56M | ﹤0.01% |
48,900
-9,900
| -17% | -$432K |
|
2337
PUT
American Water Works
AWK
$27.3B
| $2.56M | ﹤0.01% |
19,400
| – | – |
|
2338
CS Disco
LAW
$266M
| $2.56M | ﹤0.01% |
336,944
-38,781
| -10% | -$244K |
|
2339
Monster Beverage
MNST
$93.7B
| $2.55M | ﹤0.01% |
88,458
-167,498
| -65% | -$4.48M |
|
2340
PUT
Yum China
YUMC
$16.1B
| $2.55M | ﹤0.01% |
+60,000
| New | +$2.79M |
|
|
SGMO
2341
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $2.54M | ﹤0.01% |
4,683,973
+2,175,388
| +87% | +$1M |
|
2342
CALL
Martin Marietta Materials
MLM
$37.8B
| $2.54M | ﹤0.01% |
5,100
| – | – |
|
2343
Babcock & Wilcox
BW
$1.12B
| $2.54M | ﹤0.01% |
1,740,841
+1,296,703
| +292% | +$2.76M |
|
|
TMHC
2344
DELISTED
Taylor Morrison
TMHC
| $2.54M | ﹤0.01% |
47,604
+1,828
| +4% | +$81.7K |
|
2345
Merchants Bancorp
MBIN
$2.46B
| $2.53M | ﹤0.01% |
59,458
+40,434
| +213% | +$1.33M |
|
2346
STAAR Surgical
STAA
$1.15B
| $2.53M | ﹤0.01% |
+81,106
| New | +$2.91M |
|
|
ESGR
2347
DELISTED
Enstar Group
ESGR
| $2.53M | ﹤0.01% |
8,594
-3,539
| -29% | -$925K |
|
2348
Palo Alto Networks
PANW
$277B
| $2.52M | ﹤0.01% |
17,120
-519,530
| -97% | -$69.5M |
|
|
AGEN
2349
Agenus
AGEN
$371M
| $2.52M | ﹤0.01% |
+152,007
| New | +$2.52M |
|
2350
PUT
Corteva
CTVA
$55.3B
| $2.52M | ﹤0.01% |
+52,500
| New | +$2.5M |
|
Similar funds
David Shaw's Q4 2023 Portfolio in Review
As of Q4 2023, David Shaw held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
- David Shaw added most to Netflix in Q4 2023, an estimated $751M increase.
- David Shaw's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
- David Shaw fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
- David Shaw's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
- David Shaw opened 575 new positions and closed 527 in Q4 2023.
- David Shaw's portfolio value rose 19% quarter-over-quarter to $114B.
Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.